2m 2m 2m 2m 2m 2m 2m
VIRAX BIOLABS (VRAX)
NASDAQ
$2.58-$0.04 (-1.72%)
Price as of Aug 03, 2026 10:19 AM EDT- $268.5MMarket Cap
- -87.60%1-Year Change
- BiotechnologyIndustry
VIRAX BIOLABS (VRAX)
$2.58-$0.04 (-1.72%)
VRAX | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $2.62 | ||
Change | -$0.18 (-6.43%) | ||
Open | $2.78 | ||
High | $2.84 | ||
Low | $2.58 | ||
Previous Close | $2.80 | ||
Volume | 65,402 | ||
30-Day Average Volume | 4,133,599 | ||
1-Week Change | -17.87% | ||
1-Month Change | -10.88% | ||
1-Year Change | -87.60% | ||
3-Year Change | -97.36% | ||
5-Year Change | N/A | ||
Fundamentals | |||
Shares Outstanding | 102.5M | ||
Total Assets | $8.3M | ||
Market Cap | $268.5M | ||
Enterprise Value | $262.1M | ||
Period: QTR TTM FY | |||
Revenue | N/A | ||
Net Income | N/A | ||
Free Cash Flow | N/A | ||
EBIT | N/A | ||
EBITDA | N/A | ||
Net Working Capital | N/A | ||
EPS | N/A | ||
Enterprise Value/EBITDA | N/A | ||
Enterprise Value/Revenue | N/A | ||
P/B | N/A | ||
P/E | N/A | ||
PEG | N/A | ||
Price/Free Cash Flow | N/A | ||
Price/Operating Cash Flow | N/A | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | 1 : 25 | ||
Last Split Date | 06/26/2026 | ||
Earnings & Revenue